Cargando…

2016 Chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinoma

Detalles Bibliográficos
Autores principales:	Gao, Ming, Ge, Minghua, Ji, Qinghai, Cheng, Ruochuan, Lu, Hankui, Guan, Haixia, Gao, Li, Guo, Zhuming, Huang, Tao, Huang, Xiaoming, Li, Xiaoming, Lin, Yansong, Liu, Qinjiang, Ni, Xin, Pan, Yi, Qin, Jianwu, Shan, Zhongyan, Sun, Hui, Wang, Xudong, Xu, Zhengang, Yu, Yang, Zhao, Daiwei, Zhang, Naisong, Zhang, Sheng, Zheng, Ying, Zhu, Jingqiang, Li, Dapeng, Zheng, Xiangqian, Chinese Association of Thyroid Oncology, (CATO), Chinese Anti-Cancer Association
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Chinese Anti-Cancer Association 2017
Materias:	Guideline
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570598/ https://www.ncbi.nlm.nih.gov/pubmed/28948061 http://dx.doi.org/10.20892/j.issn.2095-3941.2017.0051

Ejemplares similares

2017 Chinese expert consensus on the clinical application of serum marker for thyroid cancer
por: Gao, Ming, et al.
Publicado: (2018)

Expert Consensus on Prevention and Treatment of COVID-19 Infection in Patients with Lung Cancer
por: Non-small Cell Lung Cancer Expert Committee of Chinese Society of Clinical Oncology,, et al.
Publicado: (2023)

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for colorectal cancer 2018 (English version)
por: diagnosis and treatment guidelines for colorectal cancer working group, Chinese Society of Clinical Oncology (CSCO)
Publicado: (2019)

中国肺癌低剂量CT筛查指南（2023年版）
por: Chinese Expert Group on Early Diagnosis and Treatment of Lung Cancer,, et al.
Publicado: (2023)

老年肺癌护理中国专家共识（2022版）
por: Lung Cancer Specialty Committee of Chinese Elderly Health Care Association,, et al.
Publicado: (2023)

老年肺癌外科治疗中国专家共识（2022版）
por: Lung Cancer Specialty Committee of Chinese Elderly Health Care Association, Enhanced Recovery after Surgery Specialty Committee of Tianjin Medical and Health Association,
Publicado: (2023)

Anlotinib in patients with medullary thyroid carcinoma with negative prognostic factors: A sub-analysis based on the ALTER01031 study
por: Zhao, Jingzhu, et al.
Publicado: (2022)

Active surveillance as a management strategy for papillary thyroid microcarcinoma
por: Zhang, Huan, et al.
Publicado: (2020)

Chinese guidelines on management of hepatic encephalopathy in cirrhosis
por: Xu, Xiao-Yuan, et al.
Publicado: (2019)

Anlotinib in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Randomized, Double-Blind, Multicenter Phase II Trial
por: Chi, Yihebali, et al.
Publicado: (2023)

Guidelines for Investigation and Management of Close Contacts of COVID-19 Cases
por: Chinese Center for Disease Control and Prevention,
Publicado: (2020)

Technical Guidelines for Disinfection of Special Sites for COVID-19
por: Chinese Center for Disease Control and Prevention,
Publicado: (2020)

Technical Guidelines for COVID-19 Laboratory Testing
por: Chinese Center for Disease Control and Prevention,
Publicado: (2020)

Guidelines for Personal Protection of Specific Groups from COVID-19
por: Chinese Center for Disease Control and Prevention,
Publicado: (2020)

Guidelines for COVID-19 Epidemiological Investigations
por: Chinese Center for Disease Control and Prevention,
Publicado: (2020)

编者按
por: Editorial Office of Chinese Journal of Chromatography,
Publicado: (2021)

Impact of major different variants of papillary thyroid microcarcinoma on the clinicopathological characteristics: the study of 1041 cases
por: Zhi, Jingtai, et al.
Publicado: (2017)

Clinicopathological characteristics and recurrence risk of papillary thyroid microcarcinoma in the elderly
por: Wang, Xiaofei, et al.
Publicado: (2019)

Development of an Active Surveillance or Surgery Model to Predict Lymph Node Metastasis in cN0 Papillary Thyroid Microcarcinoma
por: Zhang, Huan, et al.
Publicado: (2022)

Prediction of cervical lymph node metastases in papillary thyroid microcarcinoma by sonographic features of the primary site
por: Wei, Xi, et al.
Publicado: (2019)

A Randomized, Phase III Study of Lenvatinib in Chinese Patients with Radioiodine-Refractory Differentiated Thyroid Cancer
por: Zheng, Xiangqian, et al.
Publicado: (2021)

Preoperative predictors of lateral neck lymph node metastasis in papillary thyroid microcarcinoma
por: Liu, Zheng, et al.
Publicado: (2017)

The active surveillance management approach for patients with low risk papillary thyroid microcarcinomas: is China ready?
por: Liu, Wen, et al.
Publicado: (2022)

Risk factors for cervical lymph node metastasis in papillary thyroid microcarcinoma: a study of 1,587 patients
por: Zheng, Xiangqian, et al.
Publicado: (2019)

Ultrasonic features of papillary thyroid microcarcinoma and non-microcarcinoma
por: ZHANG, XIAO-LI, et al.
Publicado: (2014)

Multi-omics profiling of papillary thyroid microcarcinoma reveals different somatic mutations and a unique transcriptomic signature
por: Li, Qiang, et al.
Publicado: (2023)

Clinical characteristics and clinicopathological correlations of bilateral breast cancer in China: A multicenter study from Chinese Society of Breast Surgery (CSBrS-006)
por: Li, Xuelu, et al.
Publicado: (2021)

Incidence of microcarcinoma and non‐microcarcinoma in ultrasound‐found thyroid nodules
por: Chen, Zhi, et al.
Publicado: (2021)

A favorable tumor size to define papillary thyroid microcarcinoma: an analysis of 1176 consecutive cases
por: Gong, Yanping, et al.
Publicado: (2018)

Tescalcin promotes highly invasive papillary thyroid microcarcinoma by regulating FOS/ERK signaling pathway
por: Zou, Xiuhe, et al.
Publicado: (2022)

Contrastive study of two screening criteria for active surveillance in patients with low-risk papillary thyroid microcarcinoma: a retrospective analysis of 1001 patients
por: Qian, Kai, et al.
Publicado: (2017)

Multi-center investigation of breast reconstruction after mastectomy from Chinese Society of Breast Surgery: A survey based on 31 tertiary hospitals (CSBrS-004)
por: Xu, Feng, et al.
Publicado: (2021)

Risk factors for skip metastasis in patients with papillary thyroid microcarcinoma
por: Wu, Xin, et al.
Publicado: (2022)

Papillary Microcarcinoma
por: Noguchi, Shiro, et al.
Publicado: (2008)

Hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis: A multicenter propensity score-matched cohort study
por: Lei, Ziying, et al.
Publicado: (2020)

Clinical and ultrasonographic features of medullary thyroid microcarcinomas compared with papillary thyroid microcarcinomas: a retrospective analysis
por: Li, Xiaoyu, et al.
Publicado: (2020)

PROJECT ADMINISTRATION AGREEMENT KE1796
por: The European Organisation for Nuclear Research, CERN, et al.
Publicado: (2010)

A Mathematical Model to Assess the Effect of Residual Positive Lymph Nodes on the Survival of Patients With Papillary Thyroid Microcarcinoma
por: Liu, Wen, et al.
Publicado: (2022)

Predictive factors for central lymph node metastases in papillary thyroid microcarcinoma
por: Wu, Xin, et al.
Publicado: (2020)

A retrospective study of the clinical features in papillary thyroid microcarcinoma depending on age
por: Wang, Xuan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sfdupgpllgbtn3s1fv8287pt9c